DGX vs TPCS · P/E 22, rev $5.94B vs rev $31.6M
Quest Diagnostics Incorporated (DGX) versus TechPrecision Corporation Common stock (TPCS) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
TechPrecision Corporation Common stock (TPCS) is a metal fabrication company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported TPCS revenue for 2026-03-31 was $31.6M. Net income was -$1.7M. Revenue was down 7.0% from 2025-03-31 to 2026-03-31. TPCS currently screens at market cap $34.5M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. TPCS currently screens at market cap $34.5M.
Not investment advice. Open the DGX and TPCS stock pages for the full models.
Not investment advice.